Literature DB >> 8658067

Coxiella burnetii infection in subjects with HIV infection and HIV infection in patients with Q fever.

M Montes1, G Cilla, J M Marimon, J L Diaz de Tuesta, E Perez-Trallero.   

Abstract

The objective of the study was to determine whether HIV infection favors the acquisition of Coxiella burnetii infection or increases the frequency of symptomatic Coxiella infections. A total of 754 subjects were tested for Coxiella antibodies: 596 intravenous drug users (IVDUs) (306 HIV-infected IVDUs matched by aged and sex with 291 non-HIV-infected IVDUs), and 157 healthy puerperal women matched to the IVDU women. A total of 520 patients with Q fever were tested for HIV antibodies. The seroprevalence of Coxiella antibodies was similar in the 2 groups of IVDUs (19.3% of HIV + IVDUs vs 22.9% of HIV - IVDUs). Likewise, there was no difference in the prevalence of Coxiella antibodies in the groups of IVDU women and healthy women. Of the 520 subjects with acute Q fever, diagnosed between 1987 and 1992, only 4 (0.77%) had HIV infection. The proportions of HIV-infected subjects in the population of patients, with Q fever, of 20-39 years of age (the age of maximum incidence of both HIV and Coxiella infection in our region), coincided with the estimated proportions of HIV subjects in the respective general populations of the province. In conclusion, infection by Coxiella burnetii was not more frequent among HIV-infected subjects. It is not likely that Coxiella infection produces symptomatic infections more often in HIV-infected subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8658067     DOI: 10.3109/00365549509032728

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania.

Authors:  Malavika Prabhu; William L Nicholson; Aubree J Roche; Gilbert J Kersh; Kelly A Fitzpatrick; Lindsay D Oliver; Robert F Massung; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; John A Crump
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

2.  Coxiella burnetii antibody seropositivity is not a risk factor for AIDS-related non-Hodgkin lymphoma.

Authors:  Halie K Miller; Loredana Santo; M Constanza Camargo; Cheryl A Winkler; James J Goedert; Gilbert J Kersh; Charles S Rabkin
Journal:  Blood       Date:  2017-04-10       Impact factor: 22.113

Review 3.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Q Fever endocarditis: does serology predict outcome?

Authors:  Arístides de Alarcón
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 5.  Q fever endocarditis in HIV-infected patient.

Authors:  Miguel G Madariaga; Joseph Pulvirenti; Marin Sekosan; Christopher D Paddock; Sherif R Zaki
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

6.  Seroprevalence of Bartonella spp., Coxiella burnetii, and Hantavirus among people who inject drugs in Rio de Janeiro, Brazil: a retrospective assessment of a biobank.

Authors:  Tatiana Rozental; Anamaria Szrajbman Vaz da Silva; Renata Carvalho de Oliveira; Alexsandra Rodrigues de Mendonça Favacho; Maria de Lourdes Aguiar Oliveira; Francisco Inácio Bastos; Elba Regina Sampaio de Lemos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-07-19       Impact factor: 1.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.